Target Gene Sequencing To Characterize the Penicillin G Susceptibility of Neisseria meningitidis

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

Clinical isolates of Neisseria meningitidis with reduced susceptibility to penicillin G (intermediate isolates, Pen(I)) harbor alterations in the penA gene encoding the penicillin binding protein 2 (PBP2). A 402-bp DNA fragment in the 3' half of penA was sequenced from a collection of 1,670 meningococcal clinical isolates from 22 countries that spanned 60 years. Phenotyping, genotyping, and the determination of MICs of penicillin G were also performed. A total of 139 different penA alleles were detected with 38 alleles that were highly related, clustered together in maximum-likelihood analysis and corresponded to the penicillin G-susceptible isolates. The remaining 101 penA alleles were highly diverse, corresponded to different genotypes or phenotypes, and accounted for 38% of isolates, but no clonal expansion was detected. Analysis of the altered alleles that were represented by at least five isolates showed high correlation with the Pen(I) phenotype. The deduced amino acid sequence of the corresponding PBP2 comprised five amino acid residues that were always altered. This correlation was not complete for rare alleles, suggesting that other mechanisms may also be involved in conferring reduced susceptibility to penicillin. Evidence of mosaic structures through events of interspecies recombination was also detected in altered alleles. A new website was created based on the data from this work (http://neisseria.org/nm/typing/penA). These data argue for the use of penA sequencing to identify isolates with reduced susceptibility to penicillin G and as a tool to improve typing of meningococcal isolates, as well as to analyze DNA exchange among Neisseria species.

Knowledge Graph

Similar Paper

Target Gene Sequencing To Characterize the Penicillin G Susceptibility of Neisseria meningitidis
Antimicrobial Agents and Chemotherapy 2007.0
Diversity of Penicillin Binding Proteins among Clinical Streptococcus pneumoniae Strains from Portugal
Antimicrobial Agents and Chemotherapy 2008.0
Combined Real-Time PCR and Pyrosequencing Strategy for Objective, Sensitive, Specific, and High-Throughput Identification of Reduced Susceptibility to Penicillins in Neisseria meningitidis
Antimicrobial Agents and Chemotherapy 2008.0
Spread of a Chromosomal Cefixime-Resistant penA Gene among Different Neisseria gonorrhoeae Lineages
Antimicrobial Agents and Chemotherapy 2010.0
Diversity of penA Alterations and Subtypes in Neisseria gonorrhoeae Strains from Sydney, Australia, That Are Less Susceptible to Ceftriaxone
Antimicrobial Agents and Chemotherapy 2007.0
Antibiotic Susceptibility and Characteristics of Neisseria meningitidis Isolates from the African Meningitis Belt, 2000 to 2006: Phenotypic and Genotypic Perspectives
Antimicrobial Agents and Chemotherapy 2009.0
Mosaic Penicillin-Binding Protein 2 in Neisseria gonorrhoeae Isolates Collected in 2008 in San Francisco, California
Antimicrobial Agents and Chemotherapy 2009.0
Genetic Heterogeneity in pbp Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin Susceptibility
Antimicrobial Agents and Chemotherapy 2008.0
Neisseria gonorrhoeae Isolates with Reduced Susceptibility to Cefixime and Ceftriaxone: Association with Genetic Polymorphisms in penA , mtrR , porB1b , and ponA
Antimicrobial Agents and Chemotherapy 2007.0
First Molecular Characterization of Group B Streptococci with Reduced Penicillin Susceptibility
Antimicrobial Agents and Chemotherapy 2008.0